Faithward Advisors’s Amgen AMGN Stock Holding History

Faithward Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Sell	1,269 -131,223	-99%	-$44.9M	0.06%	219
2026 Q1	$6.42M	Buy	132,492 +131,119	+9,550%	+$46.7M	0.92%	32
2025 Q4	$449K	Buy	+1,373	New	+$436K	0.07%	206
2024 Q4	–	Sell	-901	Closed	-$290K	–	255
2024 Q3	$290K	Sell	901 -13	-1%	-$4.25K	0.05%	226
2024 Q2	$286K	Sell	914 -24	-3%	-$7.05K	0.05%	213
2024 Q1	$267K	Buy	+938	New	+$274K	0.05%	213
2023 Q2	–	Sell	-2,130	Closed	-$495K	–	270
2023 Q1	$495K	Buy	+2,130	New	+$523K	0.11%	109

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Faithward Advisors's AMGN Position: Q2 2026 in Review

Faithward Advisors reduced its Amgen (AMGN) stake by 99% in Q2 2026, selling an estimated $44.9M and leaving 1,269 shares worth $460K. The position accounts for 0.06% of the portfolio, ranked #219.

Faithward Advisors first reported a position in AMGN in Q1 2023 and has held it in 7 quarters since. The position peaked at $6.42M in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Faithward Advisors held 1,269 shares of Amgen worth $460K as of Q2 2026.
Faithward Advisors sold 131,223 Amgen shares in Q2 2026, an estimated $44.9M.
Amgen made up 0.06% of Faithward Advisors's portfolio in Q2 2026, its #219 holding.
Faithward Advisors first reported a position in Amgen in Q1 2023 and has held it in 7 quarters since.
Faithward Advisors's Amgen position peaked at $6.42M in Q1 2026.
3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.